Stabil-nor: an interventional, multi-center, randomized, double blinded, placebo-controlled study to investigate semaglutide add-on treatment for metabolic control in antipsychotic-using patients

Neuroscience Applied 2026 Open access

Read full text
Authors: R.A. Kroken, G.J.S. Larsen, M.B. Schou, M.A.E.A. Weibell, A. Blindheim, O. Andreassen, Egil Kjerstad, I. Sinkeviciute, F. Fathian, V. Steen, A. Torsvik, S. Appel
+3 more E.‐M. Løberg, E.W. Søfteland, E. Johnsen
DOI: 10.1016/j.nsa.2025.106788
Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Schizophrenia research and treatment Diet and metabolism studies

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
106788–106788
Publication date
1 January 2026
Language
EN